Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1997 Aug;41(8):1840–1842. doi: 10.1128/aac.41.8.1840

Voriconazole (UK-109,496) inhibits the growth and alters the morphology of fluconazole-susceptible and -resistant Candida species.

P Belanger 1, C C Nast 1, R Fratti 1, H Sanati 1, M Ghannoum 1
PMCID: PMC164020  PMID: 9257776

Abstract

The effects of voriconazole on the growth, ultrastructure, and leakage of cytoplasmic materials of Candida species were investigated. MIC data showed that voriconazole was more active than fluconazole. Exposure of yeast to voriconazole caused growth inhibition, cell wall thinning, and cell membrane degradation. Neither cell collapse nor release of cytoplasmic materials was observed in the treated cells.

Full Text

The Full Text of this article is available as a PDF (508.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ghannoum M. A. Effects of antineoplastic agents on growth, morphology and metabolism of Torulopsis glabrata. Mycopathologia. 1986 Sep;95(3):175–181. doi: 10.1007/BF00437124. [DOI] [PubMed] [Google Scholar]
  2. Ghannoum M. A., Elteen K. A., Ellabib M., Whittaker P. A. Antimycotic effects of octenidine and pirtenidine. J Antimicrob Chemother. 1990 Feb;25(2):237–245. doi: 10.1093/jac/25.2.237. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES